A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab

NCT06169527 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Dupilumab

Sponsor

Sanofi

Collaborators

[object Object]